Global Basal Insulin (Long-Acting Insulin) Market Growth 2023-2029

February 2023 | 94 pages | ID: GFA84B124332EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.

LPI (LP Information)' newest research report, the “Basal Insulin (Long-Acting Insulin) Industry Forecast” looks at past sales and reviews total world Basal Insulin (Long-Acting Insulin) sales in 2022, providing a comprehensive analysis by region and market sector of projected Basal Insulin (Long-Acting Insulin) sales for 2023 through 2029. With Basal Insulin (Long-Acting Insulin) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Basal Insulin (Long-Acting Insulin) industry.

This Insight Report provides a comprehensive analysis of the global Basal Insulin (Long-Acting Insulin) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Basal Insulin (Long-Acting Insulin) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Basal Insulin (Long-Acting Insulin) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Basal Insulin (Long-Acting Insulin) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Basal Insulin (Long-Acting Insulin).

The global Basal Insulin (Long-Acting Insulin) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Basal Insulin (Long-Acting Insulin) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Basal Insulin (Long-Acting Insulin) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Basal Insulin (Long-Acting Insulin) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Basal Insulin (Long-Acting Insulin) players cover Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico and Wockhardt, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Basal Insulin (Long-Acting Insulin) market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Lantus
• Levemir
• Tresiba
• Toujeo
• Basaglar
• Biosimilar Glargines

Segmentation by application

• Type 1 Diabetes
• Type 2 Diabetes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novo Nordisk
• Sanofi Aventis
• Eli Lilly
• Biocon
• Julphar
• Exir
• Sedico
• Wockhardt

Key Questions Addressed in this Report

What is the 10-year outlook for the global Basal Insulin (Long-Acting Insulin) market?

What factors are driving Basal Insulin (Long-Acting Insulin) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Basal Insulin (Long-Acting Insulin) market opportunities vary by end market size?

How does Basal Insulin (Long-Acting Insulin) break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Basal Insulin (Long-Acting Insulin) by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Basal Insulin (Long-Acting Insulin) by Country/Region, 2018, 2022 & 2029
2.2 Basal Insulin (Long-Acting Insulin) Segment by Type
  2.2.1 Lantus
  2.2.2 Levemir
  2.2.3 Tresiba
  2.2.4 Toujeo
  2.2.5 Basaglar
  2.2.6 Biosimilar Glargines
2.3 Basal Insulin (Long-Acting Insulin) Sales by Type
  2.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
  2.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2018-2023)
2.4 Basal Insulin (Long-Acting Insulin) Segment by Application
  2.4.1 Type 1 Diabetes
  2.4.2 Type 2 Diabetes
2.5 Basal Insulin (Long-Acting Insulin) Sales by Application
  2.5.1 Global Basal Insulin (Long-Acting Insulin) Sale Market Share by Application (2018-2023)
  2.5.2 Global Basal Insulin (Long-Acting Insulin) Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2018-2023)

3 GLOBAL BASAL INSULIN (LONG-ACTING INSULIN) BY COMPANY

3.1 Global Basal Insulin (Long-Acting Insulin) Breakdown Data by Company
  3.1.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales by Company (2018-2023)
  3.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2018-2023)
3.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue by Company (2018-2023)
  3.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2018-2023)
  3.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2018-2023)
3.3 Global Basal Insulin (Long-Acting Insulin) Sale Price by Company
3.4 Key Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Location Distribution
  3.4.2 Players Basal Insulin (Long-Acting Insulin) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR BASAL INSULIN (LONG-ACTING INSULIN) BY GEOGRAPHIC REGION

4.1 World Historic Basal Insulin (Long-Acting Insulin) Market Size by Geographic Region (2018-2023)
  4.1.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Basal Insulin (Long-Acting Insulin) Market Size by Country/Region (2018-2023)
  4.2.1 Global Basal Insulin (Long-Acting Insulin) Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Basal Insulin (Long-Acting Insulin) Sales Growth
4.4 APAC Basal Insulin (Long-Acting Insulin) Sales Growth
4.5 Europe Basal Insulin (Long-Acting Insulin) Sales Growth
4.6 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Growth

5 AMERICAS

5.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country
  5.1.1 Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023)
  5.1.2 Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023)
5.2 Americas Basal Insulin (Long-Acting Insulin) Sales by Type
5.3 Americas Basal Insulin (Long-Acting Insulin) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region
  6.1.1 APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2018-2023)
  6.1.2 APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2018-2023)
6.2 APAC Basal Insulin (Long-Acting Insulin) Sales by Type
6.3 APAC Basal Insulin (Long-Acting Insulin) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Basal Insulin (Long-Acting Insulin) by Country
  7.1.1 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023)
  7.1.2 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023)
7.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Type
7.3 Europe Basal Insulin (Long-Acting Insulin) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) by Country
  8.1.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023)
8.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type
8.3 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Basal Insulin (Long-Acting Insulin)
10.3 Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
10.4 Industry Chain Structure of Basal Insulin (Long-Acting Insulin)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Basal Insulin (Long-Acting Insulin) Distributors
11.3 Basal Insulin (Long-Acting Insulin) Customer

12 WORLD FORECAST REVIEW FOR BASAL INSULIN (LONG-ACTING INSULIN) BY GEOGRAPHIC REGION

12.1 Global Basal Insulin (Long-Acting Insulin) Market Size Forecast by Region
  12.1.1 Global Basal Insulin (Long-Acting Insulin) Forecast by Region (2024-2029)
  12.1.2 Global Basal Insulin (Long-Acting Insulin) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Basal Insulin (Long-Acting Insulin) Forecast by Type
12.7 Global Basal Insulin (Long-Acting Insulin) Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Information
  13.1.2 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Novo Nordisk Main Business Overview
  13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi Aventis
  13.2.1 Sanofi Aventis Company Information
  13.2.2 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Sanofi Aventis Main Business Overview
  13.2.5 Sanofi Aventis Latest Developments
13.3 Eli Lilly
  13.3.1 Eli Lilly Company Information
  13.3.2 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Eli Lilly Main Business Overview
  13.3.5 Eli Lilly Latest Developments
13.4 Biocon
  13.4.1 Biocon Company Information
  13.4.2 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Biocon Main Business Overview
  13.4.5 Biocon Latest Developments
13.5 Julphar
  13.5.1 Julphar Company Information
  13.5.2 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Julphar Main Business Overview
  13.5.5 Julphar Latest Developments
13.6 Exir
  13.6.1 Exir Company Information
  13.6.2 Exir Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Exir Main Business Overview
  13.6.5 Exir Latest Developments
13.7 Sedico
  13.7.1 Sedico Company Information
  13.7.2 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Sedico Main Business Overview
  13.7.5 Sedico Latest Developments
13.8 Wockhardt
  13.8.1 Wockhardt Company Information
  13.8.2 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
  13.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Wockhardt Main Business Overview
  13.8.5 Wockhardt Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Basal Insulin (Long-Acting Insulin) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Basal Insulin (Long-Acting Insulin) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Lantus
Table 4. Major Players of Levemir
Table 5. Major Players of Tresiba
Table 6. Major Players of Toujeo
Table 7. Major Players of Basaglar
Table 8. Major Players of Biosimilar Glargines
Table 9. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2023) & (K Units)
Table 10. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
Table 11. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2018-2023) & ($ million)
Table 12. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2018-2023)
Table 13. Global Basal Insulin (Long-Acting Insulin) Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2023) & (K Units)
Table 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2023)
Table 16. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2018-2023)
Table 17. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2018-2023)
Table 18. Global Basal Insulin (Long-Acting Insulin) Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Basal Insulin (Long-Acting Insulin) Sales by Company (2018-2023) & (K Units)
Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company (2018-2023)
Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2018-2023)
Table 23. Global Basal Insulin (Long-Acting Insulin) Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Basal Insulin (Long-Acting Insulin) Producing Area Distribution and Sales Area
Table 25. Players Basal Insulin (Long-Acting Insulin) Products Offered
Table 26. Basal Insulin (Long-Acting Insulin) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Basal Insulin (Long-Acting Insulin) Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Geographic Region (2018-2023)
Table 31. Global Basal Insulin (Long-Acting Insulin) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Basal Insulin (Long-Acting Insulin) Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Country/Region (2018-2023)
Table 35. Global Basal Insulin (Long-Acting Insulin) Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 38. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2023)
Table 39. Americas Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2023)
Table 41. Americas Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2023) & (K Units)
Table 42. Americas Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2023) & (K Units)
Table 43. APAC Basal Insulin (Long-Acting Insulin) Sales by Region (2018-2023) & (K Units)
Table 44. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2018-2023)
Table 45. APAC Basal Insulin (Long-Acting Insulin) Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2018-2023)
Table 47. APAC Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2023) & (K Units)
Table 48. APAC Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2023) & (K Units)
Table 49. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 50. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2023)
Table 51. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2023)
Table 53. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2023) & (K Units)
Table 54. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Basal Insulin (Long-Acting Insulin)
Table 62. Key Market Challenges & Risks of Basal Insulin (Long-Acting Insulin)
Table 63. Key Industry Trends of Basal Insulin (Long-Acting Insulin)
Table 64. Basal Insulin (Long-Acting Insulin) Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Basal Insulin (Long-Acting Insulin) Distributors List
Table 67. Basal Insulin (Long-Acting Insulin) Customer List
Table 68. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Basal Insulin (Long-Acting Insulin) Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Basal Insulin (Long-Acting Insulin) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Basal Insulin (Long-Acting Insulin) Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Basal Insulin (Long-Acting Insulin) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Novo Nordisk Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 83. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 84. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Novo Nordisk Main Business
Table 86. Novo Nordisk Latest Developments
Table 87. Sanofi Aventis Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 89. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Sanofi Aventis Main Business
Table 91. Sanofi Aventis Latest Developments
Table 92. Eli Lilly Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 94. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Eli Lilly Main Business
Table 96. Eli Lilly Latest Developments
Table 97. Biocon Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 98. Biocon Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 99. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Biocon Main Business
Table 101. Biocon Latest Developments
Table 102. Julphar Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 103. Julphar Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 104. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Julphar Main Business
Table 106. Julphar Latest Developments
Table 107. Exir Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 108. Exir Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 109. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Exir Main Business
Table 111. Exir Latest Developments
Table 112. Sedico Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 113. Sedico Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 114. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Sedico Main Business
Table 116. Sedico Latest Developments
Table 117. Wockhardt Basic Information, Basal Insulin (Long-Acting Insulin) Manufacturing Base, Sales Area and Its Competitors
Table 118. Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolios and Specifications
Table 119. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Wockhardt Main Business
Table 121. Wockhardt Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Basal Insulin (Long-Acting Insulin)
Figure 2. Basal Insulin (Long-Acting Insulin) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Basal Insulin (Long-Acting Insulin) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Basal Insulin (Long-Acting Insulin) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Basal Insulin (Long-Acting Insulin) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Lantus
Figure 10. Product Picture of Levemir
Figure 11. Product Picture of Tresiba
Figure 12. Product Picture of Toujeo
Figure 13. Product Picture of Basaglar
Figure 14. Product Picture of Biosimilar Glargines
Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2022
Figure 16. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2018-2023)
Figure 17. Basal Insulin (Long-Acting Insulin) Consumed in Type 1 Diabetes
Figure 18. Global Basal Insulin (Long-Acting Insulin) Market: Type 1 Diabetes (2018-2023) & (K Units)
Figure 19. Basal Insulin (Long-Acting Insulin) Consumed in Type 2 Diabetes
Figure 20. Global Basal Insulin (Long-Acting Insulin) Market: Type 2 Diabetes (2018-2023) & (K Units)
Figure 21. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2022)
Figure 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application in 2022
Figure 23. Basal Insulin (Long-Acting Insulin) Sales Market by Company in 2022 (K Units)
Figure 24. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Company in 2022
Figure 25. Basal Insulin (Long-Acting Insulin) Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company in 2022
Figure 27. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Basal Insulin (Long-Acting Insulin) Sales 2018-2023 (K Units)
Figure 30. Americas Basal Insulin (Long-Acting Insulin) Revenue 2018-2023 ($ Millions)
Figure 31. APAC Basal Insulin (Long-Acting Insulin) Sales 2018-2023 (K Units)
Figure 32. APAC Basal Insulin (Long-Acting Insulin) Revenue 2018-2023 ($ Millions)
Figure 33. Europe Basal Insulin (Long-Acting Insulin) Sales 2018-2023 (K Units)
Figure 34. Europe Basal Insulin (Long-Acting Insulin) Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue 2018-2023 ($ Millions)
Figure 37. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2022
Figure 38. Americas Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2022
Figure 39. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
Figure 40. Americas Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2023)
Figure 41. United States Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Region in 2022
Figure 46. APAC Basal Insulin (Long-Acting Insulin) Revenue Market Share by Regions in 2022
Figure 47. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
Figure 48. APAC Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2023)
Figure 49. China Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2022
Figure 57. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2022
Figure 58. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
Figure 59. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2023)
Figure 60. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2018-2023)
Figure 69. Egypt Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Basal Insulin (Long-Acting Insulin) Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Basal Insulin (Long-Acting Insulin) in 2022
Figure 75. Manufacturing Process Analysis of Basal Insulin (Long-Acting Insulin)
Figure 76. Industry Chain Structure of Basal Insulin (Long-Acting Insulin)
Figure 77. Channels of Distribution
Figure 78. Global Basal Insulin (Long-Acting Insulin) Sales Market Forecast by Region (2024-2029)
Figure 79. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Basal Insulin (Long-Acting Insulin) Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share Forecast by Application (2024-2029)